Calamos Advisors’s QuidelOrtho QDEL Stock Holding History

Calamos Advisors’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,975	Closed	-$3.07M	–	757
2020 Q3	$3.07M	Buy	13,975 +4,982	+55%	+$1.11M	0.02%	534
2020 Q2	$2.01M	Buy	+8,993	New	+$1.41M	0.01%	579
2019 Q1	–	Sell	-6,310	Closed	-$308K	–	707
2018 Q4	$308K	Sell	6,310 -160	-2%	-$9.55K	﹤0.01%	620
2018 Q3	$422K	Buy	+6,470	New	+$452K	﹤0.01%	603

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Calamos Advisors's QDEL Position: Q4 2020 in Review

Calamos Advisors sold out of QuidelOrtho (QDEL) in Q4 2020, closing a stake of 13,975 shares — an estimated $3.07M sold.

Calamos Advisors first reported a position in QDEL in Q3 2018 and held it in 4 quarters. The position peaked at $3.07M in Q3 2020. 386 funds tracked by Wall St. Rank hold QDEL as of Q4 2020.

Calamos Advisors reported no remaining QuidelOrtho position as of Q4 2020 after selling out during the quarter.
Calamos Advisors sold 13,975 QuidelOrtho shares in Q4 2020, an estimated $3.07M.
Calamos Advisors first reported a position in QuidelOrtho in Q3 2018 and held it in 4 quarters.
Calamos Advisors's QuidelOrtho position peaked at $3.07M in Q3 2020.
386 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2020.

Based on Calamos Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.